Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06496282

Lemborexant on Improving Sleep Quality Among Hospital Rotating Shift Workers

The Efficacy of Lemborexant Versus Placebo on Improving Sleep Quality Among Hospital Rotating Shift Workers: A Randomized, Double-Blind, Placebo-Controlled Trial

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Phramongkutklao College of Medicine and Hospital · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

Shift Work Sleep Disorder (SWSD) are caused by working shifts with a wake-up schedule and sleeping in a way that is different from the natural way of sleeping and avoiding sleep usually results in deviations. of the biological clock (Biological clock), which is an important cause of sleep problems including insomnia, excessive sleepiness or daytime sleepiness these problems was associated cadiovascular events, decrease quality of life and long term working. At the present there are limited information regarding the effectiveness of medications used to promote sleep in shift workers. Lemborexant is specific in binding to orexin type 2, which has a direct effect on sleep. and there are limited biomarkers monitoring from the use of lemborexant including still not found. Which studies have followed depressive symptoms, anxiety symptoms and cognition from a group of people with insomnia, the aim of study to assessment effectiveness of lemborexant on sleep efficiency, quality of life, symptoms of depression, cognition, BDNF, CRP, IL-6 and TNF-alpha levels. of volunteers working on rotating shifts.

Conditions

Interventions

TypeNameDescription
DRUGLemborexantThe participants will receive lemborexant for improving sleep quality at lease 30 days in 6 weeks of study
DRUGPlaceboThe participants will receive placebo for improving sleep quality at lease 30 days in 6 weeks of study

Timeline

Start date
2024-08-01
Primary completion
2026-05-31
Completion
2026-07-01
First posted
2024-07-11
Last updated
2024-07-11

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT06496282. Inclusion in this directory is not an endorsement.